PT Prodia Widyahusada Tbk (PRDA.JK)
IDR 2600.0
(-1.52%)
IDR 2600.0
(-1.52%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 527.17 Billion IDR | -19.14% |
| 2022 | 629.25 Billion IDR | -34.58% |
| 2021 | 948.89 Billion IDR | 98.18% |
| 2020 | 490.76 Billion IDR | 36.76% |
| 2019 | 357.08 Billion IDR | 16.14% |
| 2018 | 311.36 Billion IDR | 15.06% |
| 2017 | 272.7 Billion IDR | 53.23% |
| 2016 | 182.65 Billion IDR | 85.62% |
| 2015 | 131.79 Billion IDR | -20.95% |
| 2014 | 121.47 Billion IDR | -0.75% |
| 2013 | 120.11 Billion IDR | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | 90.45 Billion IDR | 15.88% |
| 2024 Q3 | 182.6 Billion IDR | 1.62% |
| 2024 Q2 | 128.8 Billion IDR | 39.47% |
| 2023 Q2 | 130.01 Billion IDR | 6.59% |
| 2023 Q1 | 121.97 Billion IDR | -20.13% |
| 2023 FY | - IDR | -19.14% |
| 2023 Q4 | 76.03 Billion IDR | -49.86% |
| 2023 Q3 | 151.63 Billion IDR | 16.62% |
| 2022 Q2 | 99.78 Billion IDR | -39.0% |
| 2022 Q1 | 163.57 Billion IDR | -4.6% |
| 2022 FY | - IDR | -34.58% |
| 2022 Q3 | 181.54 Billion IDR | 81.95% |
| 2022 Q4 | 152.71 Billion IDR | -15.88% |
| 2021 Q2 | 212.38 Billion IDR | -8.45% |
| 2021 Q3 | 297.69 Billion IDR | 40.17% |
| 2021 Q4 | 171.46 Billion IDR | -42.4% |
| 2021 FY | - IDR | 98.18% |
| 2021 Q1 | 231.98 Billion IDR | 5.16% |
| 2020 Q4 | 220.59 Billion IDR | 12.09% |
| 2020 Q1 | 69.48 Billion IDR | -49.32% |
| 2020 Q2 | -25.93 Billion IDR | -137.32% |
| 2020 Q3 | 196.8 Billion IDR | 858.99% |
| 2020 FY | - IDR | 36.76% |
| 2019 Q3 | 65.17 Billion IDR | 11.84% |
| 2019 Q4 | 137.1 Billion IDR | 110.37% |
| 2019 Q2 | 58.27 Billion IDR | -23.84% |
| 2019 Q1 | 76.51 Billion IDR | -30.82% |
| 2019 FY | - IDR | 16.14% |
| 2018 Q4 | 110.59 Billion IDR | 48.99% |
| 2018 Q3 | 74.23 Billion IDR | 47.22% |
| 2018 Q2 | 50.42 Billion IDR | -8.25% |
| 2018 Q1 | 54.95 Billion IDR | -42.65% |
| 2018 FY | - IDR | 15.06% |
| 2017 Q4 | 95.83 Billion IDR | 6.38% |
| 2017 FY | - IDR | 53.23% |
| 2017 Q3 | 90.08 Billion IDR | 1730.47% |
| 2017 Q2 | 4.92 Billion IDR | -88.25% |
| 2017 Q1 | 41.87 Billion IDR | -53.42% |
| 2016 Q1 | 33.97 Billion IDR | 41.74% |
| 2016 Q2 | 25.26 Billion IDR | -25.64% |
| 2016 Q3 | -898.45 Million IDR | -103.56% |
| 2016 Q4 | 89.9 Billion IDR | 10106.44% |
| 2016 FY | - IDR | 85.62% |
| 2015 Q2 | 36.27 Billion IDR | -0.0% |
| 2015 Q4 | 23.96 Billion IDR | 0.0% |
| 2015 FY | - IDR | -20.95% |
| 2015 Q1 | 36.27 Billion IDR | 0.0% |
| 2015 Q3 | 23.96 Billion IDR | -33.94% |
| 2014 FY | - IDR | -0.75% |
| 2013 FY | - IDR | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| PT Diagnos Laboratorium Utama Tbk | 1.53 Billion IDR | -34269.522% |